Company:  LIGAND PHARMACEUTICALS IN ... (LGND)
Form Type:  S-8
Filing Date:  8/8/2019 
CIK:  0000886163 
Address:  3911 SORRENTO VALLEY BLVD
SUITE 110
 
City, State, Zip:  SAN DIEGO, California 92121 
Telephone:  858-550-7500 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$102.44  
Change: 
0.87 (0.86%)  
Trade Time: 
12:11 PM EST  
Market Cap: 
$1.64B
Trade LGND now with 

© 2020  
Description of Business
We are a biopharmaceutical company focused on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. We employ research technologies such as antibody discovery technologies, structure-based drug design, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals. We currently have partnerships and license agreements with over 120 pharmaceutical and biotechnology companies. Over 200 different programs are in various stages of commercialization and development and fully funded by our collaboration partners and licensees. We have contributed novel research and technologies for approved medicines that treat cancer, osteoporosis, fungal infections and PPD, among others.
Register and access this filing in:     
  FORM S-8
    CALCULATION OF REGISTRATION FEE
    EXPLANATORY NOTE
    PART I
    PART II
      Item 3. Incorporation of Documents by Reference.
    Item 4. Description of Securities.
    Item 5. Interests of Named Experts and Counsel.
      Item 6. Indemnification of Directors and Officers.
      Item 7. Exemption from Registration Claimed.
      Item 8. Exhibits.
      Item 9. Undertakings.
    SIGNATURES
    POWER OF ATTORNEY
  EXHIBIT 3.6
    CERTIFICATE OF INCORPORATION
  EXHIBIT 5.1
  EXHIBIT 23.1
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM